---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-071449"
form_type: "8-K"
ticker: null
cik: "0001835416"
company_name: "Moringa Acquisition Corp"
filed_at: "2024-08-21T23:59:59+00:00"
generated_at: "2026-05-31T08:17:58.816606+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Moringa Acquisition Corp completes de-SPAC merger with Silexion; begins trading as SLXN

## Summary
- Business combination closed Aug. 15, 2024; combined company renamed Silexion Therapeutics Corp, trading on Nasdaq under SLXN and SLXNW starting Aug. 16, 2024.
- Redemptions: 427,297 Moringa Class A shares redeemed; 87,722 public shares remained and converted into New Pubco ordinary shares.
- Post-combination: 9,768,396 ordinary shares and 5,940,000 warrants outstanding; Greenstar, L.P. purchased 200,000 shares at $10 each ($2M) in a private placement.
- Directors Ruth Alon, Michael Basch, Eric Brachfeld, Craig Marshak resigned; CEO Ilan Levin and CFO Gil Maman left; Ilan Hadar appointed as director.
- Moringa securities delisted from Nasdaq; public shareholders who did not redeem received shares of the combined company.

## SEC filing metadata
- accession: 0001213900-24-071449
- form_type: 8-K
- cik: 0001835416
- company_name: Moringa Acquisition Corp
- filed_at: 2024-08-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01, 3.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/ea0212019-8k_moringa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-071449
- JSON: https://secwatch.observer/filing/0001213900-24-071449.json
- Plain text: https://secwatch.observer/filing/0001213900-24-071449.txt

## Key facts
- Executive change
  Eric Brachfeld departed as Director at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Director
  source text: each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Ilan Levin departed as Chief Executive Officer at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Chief Executive Officer
  source text: Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Michael Basch departed as Director at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Director
  source text: each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Ilan Hadar was appointed as Director at Moringa Acquisition Corp.
  - Action: appointed
  - Role: Director
  source text: Ilan Hadar was appointed a director of Moringa immediately following the consummation of the Business Combination
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Craig Marshak departed as Director at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Director
  source text: each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Gil Maman departed as Chief Financial Officer at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Chief Financial Officer
  source text: Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
- Executive change
  Ruth Alon departed as Director at Moringa Acquisition Corp.
  - Action: ceased
  - Role: Director
  source text: each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.